Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2006;332:193 (28 January), doi:10.1136/bmj.332.7535.193-a
Lynn Eaton
London
| The first 150 words of the full text of this article appear below. |
The New England Journal of Medicine has joined the Lancet in issuing a statement of concern about papers the journals published by the Norwegian researcher Jon Sudbø, currently at the centre of allegations of research fraud.
It follows an announcement by officials at Radium Hospital in Oslo that Dr Sudbø, a senior consultant who wrote a paper on the link between non-steroidal anti-inflammatory drugs and oral cancer, has told his employers that data were faked.
The study published by the Lancet in October (2005;366: 1359-66) claimed to be based on information from a national database.
In its summary of the methods used, Dr Sudbø's paper said: "We undertook a nested case-control study to analyse data from a population-based database (Cohort of Norway; CONOR), which consisted of prospectively obtained health data from all regions of Norway."
It has emerged that, although the database in question did exist, it was not open
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
StumbleUpon
Technorati What's this?
Read all Rapid Responses